We are live on ! Find out more
AMH

Aspex Management (HK) Portfolio holdings

AUM $6.9B
1-Year Est. Return 28.37%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+28.37%
3 Year Est. Return
+152.59%
5 Year Est. Return
+77.04%
10 Year Est. Return
AUM
$2.53B
AUM Growth
-$9.16M
Cap. Flow
+$20M
Cap. Flow %
0.79%
Top 10 Hldgs %
81.75%
Holding
26
New
3
Increased
8
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$92.1M
2
JD icon
JD.com
JD
+$82.6M
3
YSG
Yatsen Holding
YSG
+$55.9M
4
XPEV icon
XPeng
XPEV
+$52M
5
ZH
Zhihu
ZH
+$31.2M

Top Sells

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$119M
2
ZTO icon
ZTO Express
ZTO
+$52.6M
3
MNSO icon
MINISO
MNSO
+$50M
4
NIO icon
NIO
NIO
+$44.9M
5
BEKE icon
KE Holdings
BEKE
+$40.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 46.06%
2 Technology 23.82%
3 Financials 11.26%
4 Real Estate 5.64%
5 Consumer Staples 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEV icon
1
XPeng
XPEV
$11.8B
$425M 16.81%
11,629,425
+1,250,000
+12% +$52M
JD icon
2
JD.com
JD
$40.8B
$327M 12.94%
3,873,792
+901,100
+30% +$82.6M
GDS icon
3
GDS Holdings
GDS
$6.34B
$268M 10.6%
3,302,293
+71,200
+2% +$7.1M
QFIN icon
4
Qfin Holdings
QFIN
$1.61B
$238M 9.43%
9,157,633
+1,182,275
+15% +$26.3M
MU icon
5
Micron Technology
MU
$1.04T
$177M 7.02%
2,011,217
+1,085,592
+117% +$92.1M
LRCX icon
6
Lam Research
LRCX
$382B
$156M 6.2%
2,629,070
+128,000
+5% +$6.97M
BEKE icon
7
KE Holdings
BEKE
$16.8B
$142M 5.64%
2,500,000
-646,514
-21% -$40.6M
PDD icon
8
Pinduoduo
PDD
$118B
$131M 5.18%
976,900
-23,100
-2% -$3.9M
HTHT icon
9
Huazhu Hotels Group
HTHT
$12.4B
$100M 3.96%
1,823,523
+534,823
+42% +$28.6M
LI icon
10
Li Auto
LI
$12.6B
$100M 3.96%
4,000,000
-500,000
-11% -$14.5M
NIO icon
11
NIO
NIO
$11.3B
$81M 3.21%
2,079,000
-881,840
-30% -$44.9M
NFH
12
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$46.1M 1.83%
4,081,250
YSG
13
Yatsen Holding
YSG
$311M
$44.2M 1.75%
715,337
+615,337
+615% +$55.9M
ZH
14
Zhihu
ZH
$270M
$31.6M 1.25%
+650,000
New +$31.2M
EDU icon
15
New Oriental
EDU
$7.84B
$10.7M 0.42%
+76,267
New +$13.3M
OPA.U
16
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$9.8M 0.39%
+991,394
New +$9.79M
NFH.WS
17
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$380K 0.02%
162,500
BNR
18
Burning Rock Biotech
BNR
-48,642
Closed -$11.2M
LVS icon
19
Las Vegas Sands
LVS
$30.5B
-1,999,664
Closed -$119M
MNSO icon
20
MINISO
MNSO
$3.64B
-1,893,673
Closed -$50M
ZTO icon
21
ZTO Express
ZTO
$18.2B
-1,803,610
Closed -$52.6M
JOYY
22
JOYY Inc
JOYY
$3.73B
-324,557
Closed -$26M

Similar funds

Aspex Management (HK)'s Q1 2021 Portfolio in Review

As of Q1 2021, Aspex Management (HK) held 26 positions worth $2.53B, down 0.36% from $2.53B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Aspex Management (HK)'s Q1 2021 filing shows 3 new, 8 increased, 5 reduced and 5 closed positions. Its largest new stake was Zhihu: 650,000 shares worth $31.6M. The largest sale was Las Vegas Sands, an estimated $119M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 55% a quarter earlier, followed by Technology and Financials.

  • Aspex Management (HK)'s largest Q1 2021 buy was Zhihu: 650,000 shares worth $31.6M.
  • Aspex Management (HK) added most to Micron Technology in Q1 2021, an estimated $92.1M increase.
  • Aspex Management (HK)'s biggest Q1 2021 reduction was NIO, cutting an estimated $44.9M.
  • Aspex Management (HK) fully exited Las Vegas Sands in Q1 2021, selling an estimated $119M.
  • Aspex Management (HK)'s ten largest holdings make up 82% of its $2.53B portfolio in Q1 2021.
  • Aspex Management (HK) opened 3 new positions and closed 5 in Q1 2021.
  • Aspex Management (HK)'s portfolio value fell 0.36% quarter-over-quarter to $2.53B.

Based on Aspex Management (HK)'s 13F filing for Q1 2021, filed 14 May 2021.